z-logo
Premium
Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No Confidence
Author(s) -
Ferrari Serge
Publication year - 2020
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.4022
Subject(s) - denosumab , discontinuation , zoledronic acid , medicine , library science , family medicine , psychology , computer science , osteoporosis

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom